» Articles » PMID: 16571592

Mesangial Cells Initiate Compensatory Renal Tubular Hypertrophy Via IL-10-induced TGF-beta Secretion: Effect of the Immunomodulator AS101 on This Process

Overview
Specialties Nephrology
Physiology
Date 2006 Mar 31
PMID 16571592
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigated the role of IL-10 produced by the mesangial cells in postnephrectomy compensatory renal growth and the effect of the immunomodulator AS101 on this process. One hundred forty unilateral nephrectomized and sham-operated male Sprague-Dawley rats were treated by AS101 or PBS before and after surgery. The results show that secretion of IL-10 and TGF-beta by mesangial cells isolated from the remaining kidneys was increased significantly, compared with those of control and sham animals. Moreover, TGF-beta secretion by mesangial cells was increased after the addition of exogenous recombinant IL-10 and inhibited in the presence of neutralizing anti-IL-10 antibodies. In vivo, compensatory growth of the remaining kidneys was associated with significant increase in IL-10 content in renal tissues and plasma. Immunohistochemical studies show that IL-10 was produced by mesangial cells. Elevated IL-10 levels were followed by the rise in TGF-beta content in plasma and renal tissue. AS101 treatment decreased IL-10 and TGF-beta expression in plasma and kidney tissues and results in 25% reduction in the fresh and fractional kidney weight and decreased hypertrophy of tubular cells (protein/DNA ratio, morphometric analysis). Taken together, these data demonstrate that TGF-beta production by mesangial cells is IL-10 dependent. Mesangial cells are the major source of IL-10 in kidneys. AS101, by inhibiting the activity of IL-10, decreases TGF-beta production by mesangial cells, thus limiting compensatory tubular cell hypertrophy.

Citing Articles

Temporal Alterations in Mitochondrial β-Oxidation and Oxidative Stress Aggravate Chronic Kidney Disease Development in 5/6 Nephrectomy Induced Renal Damage.

Aparicio-Trejo O, Rojas-Morales P, Avila-Rojas S, Leon-Contreras J, Hernandez-Pando R, Jimenez-Uribe A Int J Mol Sci. 2020; 21(18).

PMID: 32899919 PMC: 7555424. DOI: 10.3390/ijms21186512.


Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.

Midgley A, Wei Y, Zhu D, Gao F, Yan H, Khalique A J Am Soc Nephrol. 2020; 31(10):2292-2311.

PMID: 32769144 PMC: 7609017. DOI: 10.1681/ASN.2019111160.


N6-(2-Hydroxyethyl) Adenosine From Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-β1/Smad and NF-κB Signaling Pathway.

Zheng R, Zhu R, Li X, Li X, Shen L, Chen Y Front Physiol. 2018; 9:1229.

PMID: 30233405 PMC: 6131671. DOI: 10.3389/fphys.2018.01229.


Angiotensin II-Induced End-Organ Damage in Mice Is Attenuated by Human Exosomes and by an Exosomal Y RNA Fragment.

Cambier L, Giani J, Liu W, Ijichi T, Echavez A, Valle J Hypertension. 2018; 72(2):370-380.

PMID: 29866742 PMC: 6043385. DOI: 10.1161/HYPERTENSIONAHA.118.11239.


YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.

Wang J, Djudjaj S, Gibbert L, Lennartz V, Breitkopf D, Rauen T J Cell Mol Med. 2017; 21(12):3494-3505.

PMID: 28664613 PMC: 5706504. DOI: 10.1111/jcmm.13260.